← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

XWEL logoXWELL, Inc.(XWEL)Earnings, Financials & Key Ratios

XWEL•NASDAQ
$1.27
$7M mkt cap·Price updated May 7, 2026
SectorConsumer CyclicalIndustryPersonal ServicesSub-IndustryHealth, Fitness and Wellness Services
AboutXWELL Inc., a health and wellness services company, provides spa services at airports. It operates through XpresSpa, XpresTest, Treat, and HyperPointe brands. The company offers spa services, including massage, and nail and skin care, as well as spa and travel products; and retail products. It also operates wellness centers that provides COVID-19 screening and testing, and rapid testing services for other communicable diseases, such as influenza, COVID-19, RSV, Flu A&B, and seasonal flu vaccination services; and other medical diagnostic testing services. In addition, the company offers services through an integrated digital platform, and a relevant retail offering to the traveling public. As of December 31, 2021, it operated 52 spa and clinic locations in 24 airports in the United States, the Netherlands, and the United Arab Emirates. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL Inc. in October 2022. XWELL Inc. is headquartered in New York, New York.Show more
  • Revenue$29M-13.8%
  • EBITDA-$8M+51.9%
  • Net Income-$17M-0.8%
  • EPS (Diluted)-5.08-38.8%
  • Gross Margin22.75%-13.6%
  • EBITDA Margin-25.94%+44.2%
  • Operating Margin-32.03%+35.0%
  • Net Margin-58.17%-17.0%
  • ROIC-124.76%-87.1%
  • Interest Coverage-118.98-76.0%
Technical→

XWEL Key Insights

XWELL, Inc. (XWEL) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Strong 5Y profit CAGR of 28.4%
  • ✓Momentum leader: RS Rating 80 (top 20%)
  • ✓Strong 5Y sales CAGR of 28.4%
  • ✓Healthy dividend yield of 3.8%
  • ✓Efficient asset utilization: 2.6x turnover

✗Weaknesses

  • ✗Weak Piotroski F-Score: 2/9
  • ✗Negative free cash flow
  • ✗Shares diluted 20.6% in last year
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

XWEL Price & Volume

XWELL, Inc. (XWEL) stock price & volume — 10-year historical chart

Loading chart...

XWEL Growth Metrics

XWELL, Inc. (XWEL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years2.56%
5 Years28.35%
3 Years-19.47%
TTM-13.83%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-0.82%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-38.8%

Return on Capital

10 Years-66.6%
5 Years-59.78%
3 Years-88.58%
Last Year-129.47%

XWEL Peer Comparison

XWELL, Inc. (XWEL) competitors in Health, Fitness and Wellness Services — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
SKIN logoSKINThe Beauty Health CompanyDirect Competitor117.92M0.91-5.69-10.02%-2.03%-9.41%6.20
FWRG logoFWRGFirst Watch Restaurant Group, Inc.Direct Competitor736.66M11.9538.5520.34%1.38%2.85%1.18
MNST logoMNSTMonster Beverage CorporationProduct Competitor74.29B75.9739.1610.7%22.97%25.65%
PLNT logoPLNTPlanet Fitness, Inc.Product Competitor3.52B44.0116.8012.06%16.52%
XPOF logoXPOFXponential Fitness, Inc.Product Competitor244.02M6.54-4.45-1.71%-11.28%
AAL logoAALAmerican Airlines Group Inc.Supply Chain8.7B13.1877.530.78%0.36%
DAL logoDALDelta Air Lines, Inc.Supply Chain47.75B73.119.542.79%7.9%24.12%1.02
UAL logoUALUnited Airlines Holdings, Inc.Supply Chain32.37B99.709.763.52%6.06%24.91%2.03

Compare XWEL vs Peers

XWELL, Inc. (XWEL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs SKIN

Most directly comparable listed peer for XWEL.

Scale Benchmark

vs WELL

Larger-name benchmark to compare XWEL against a more recognizable public peer.

Peer Set

Compare Top 5

vs SKIN, FWRG, MNST, PLNT

XWEL Income Statement

XWELL, Inc. (XWEL) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Sales/Revenue48.82M50.09M48.52M8.38M73.73M55.94M30.11M33.9M29.21M
Revenue Growth %157.32%2.6%-3.15%-82.72%779.3%-24.13%-46.18%12.58%-13.83%
Cost of Goods Sold39.34M39.45M37.85M11.98M41.38M43.89M26.43M24.98M22.57M
COGS % of Revenue80.58%78.75%78.03%142.91%56.13%78.46%87.77%73.69%77.25%
Gross Profit
9.48M▲ 0%
10.64M▲ 12.3%
10.66M▲ 0.2%
-3.6M▼ 133.7%
32.34M▲ 998.9%
12.05M▼ 62.8%
3.68M▼ 69.4%
8.92M▲ 142.3%
6.64M▼ 25.5%
Gross Margin %19.42%21.25%21.97%-42.91%43.87%21.54%12.23%26.31%22.75%
Gross Profit Growth %54.02%12.27%0.17%-133.75%998.94%-62.75%-69.45%142.3%-25.51%
Operating Expenses24.55M25.74M26.53M36.51M28.24M43.21M31.89M25.63M16M
OpEx % of Revenue50.29%51.38%54.69%435.37%38.3%77.25%105.91%75.6%54.78%
Selling, General & Admin16.58M16.24M14.32M15.94M24.2M31.17M20.91M20.08M16M
SG&A % of Revenue33.95%32.42%29.51%190.1%32.82%55.72%69.45%59.24%54.78%
Research & Development000000000
R&D % of Revenue---------
Other Operating Expenses-197K498K12.21M20.57M4.04M12.04M10.98M5.54M0
Operating Income
-15.07M▲ 0%
-34.73M▼ 130.4%
-15.87M▲ 54.3%
-40.1M▼ 152.7%
4.11M▲ 110.2%
-31.16M▼ 858.8%
-28.21M▲ 9.5%
-16.71M▲ 40.8%
-9.36M▲ 44.0%
Operating Margin %-30.87%-69.32%-32.72%-478.28%5.57%-55.71%-93.68%-49.29%-32.03%
Operating Income Growth %32.76%-130.38%54.29%-152.67%110.24%-858.78%9.49%40.77%44%
EBITDA-8.23M-25.23M-8.43M-32.88M7.31M-25.73M-24.66M-15.77M-7.58M
EBITDA Margin %-16.85%-50.36%-17.38%-392.12%9.91%-46%-81.9%-46.52%-25.94%
EBITDA Growth %61%-206.6%66.57%-289.84%122.23%-452.13%4.17%36.05%51.94%
D&A (Non-Cash Add-back)6.84M9.5M7.44M7.22M3.2M5.43M3.55M938K1.78M
EBIT-15.27M-34.08M-17.78M-24.75M4.94M-24.55M-19.3M-12.1M-15.94M
Net Interest Income-731K-1.83M-2.9M-2.08M0-78K127K201K527K
Interest Income0001.83M0384K448K380K661K
Interest Expense731K1.83M2.9M1.83M0462K321K179K134K
Other Income/Expense-1.28M-1.18M-4.8M-52.12M-1.16M-1.41M212K266K-6.72M
Pretax Income
-16M▲ 0%
-35.91M▼ 124.4%
-20.68M▲ 42.4%
-92.22M▼ 346.0%
2.95M▲ 103.2%
-32.57M▼ 1204.6%
-27.99M▲ 14.1%
-16.44M▲ 41.3%
-16.08M▲ 2.2%
Pretax Margin %-32.77%-71.68%-42.62%-1099.88%4%-58.23%-92.98%-48.5%-55.04%
Income Tax111K-278K-146K7K56K55K35K49K29K
Effective Tax Rate %-0.69%0.77%0.71%-0.01%1.9%-0.17%-0.13%-0.3%-0.18%
Net Income
-28.84M▲ 0%
-37.2M▼ 29.0%
-21.22M▲ 43.0%
-90.49M▼ 326.4%
3.35M▲ 103.7%
-32.84M▼ 1080.5%
-27.74M▲ 15.5%
-16.85M▲ 39.2%
-16.99M▼ 0.8%
Net Margin %-59.07%-74.27%-43.75%-1079.17%4.54%-58.7%-92.14%-49.72%-58.17%
Net Income Growth %-20.14%-29%42.96%-326.37%103.7%-1080.5%15.52%39.25%-0.82%
Net Income (Continuing)-16.11M-35.63M-20.53M-92.23M2.89M-32.63M-28.03M-16.49M-16.11M
Discontinued Operations0-814K0000000
Minority Interest4.96M4.03M3.7M2.56M7.2M8.02M7.97M8.53M9.46M
EPS (Diluted)
-1552.88▲ 0%
-1535.68▲ 1.1%
-251.22▲ 83.6%
-41.39▲ 83.5%
0.60▲ 101.4%
-6.97▼ 1261.7%
-6.64▲ 4.7%
-3.66▲ 44.9%
-5.08▼ 38.8%
EPS Growth %18.24%1.11%83.64%83.52%101.45%-1261.67%4.73%44.88%-38.8%
EPS (Basic)-1552.88-1535.68-251.22-41.390.60-6.97-6.64-3.66-5.08
Diluted Shares Outstanding18.57K24.23K81.72K2.23M5.25M4.68M4.18M4.61M5.56M
Basic Shares Outstanding18.57K24.23K81.72K2.23M5.22M4.68M4.18M4.61M5.56M
Dividend Payout Ratio---------

XWEL Balance Sheet

XWELL, Inc. (XWEL) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Total Current Assets16.09M5.76M3.93M91.78M108.98M47.33M26.57M15.34M5.91M
Cash & Short-Term Investments6.37M3.4M2.18M89.8M105.51M42.19M23.05M11.8M2.62M
Cash Only6.37M3.4M2.18M89.8M105.51M19.04M8.44M4.55M2.62M
Short-Term Investments0000023.15M14.61M7.25M7K
Accounts Receivable800K000615K2.86M1.67M1.79M1.56M
Days Sales Outstanding5.98---3.0418.6520.2119.3119.49
Inventory1.16M782K647K657K1.76M1.16M900K501K509K
Days Inventory Outstanding10.757.246.2420.0115.559.6512.437.328.23
Other Current Assets6.55M370K118K186K48K48K55K56K1.22M
Total Non-Current Assets49.15M24.82M24.79M11.36M18.29M23.09M12.43M10.02M5.31M
Property, Plant & Equipment15.8M11.79M16.32M7.2M11M11.94M7.11M5.22M2.7M
Fixed Asset Turnover3.09x4.25x2.97x1.17x6.71x4.68x4.23x6.50x10.80x
Goodwill19.63M00004.02M1.37M1.39M0
Intangible Assets11.55M9.17M6.78M870K3.73M4.01M1.35M1.02M101K
Long-Term Investments2.81M2.48M484K1.77M722K104K50K85K0
Other Non-Current Assets2.17M487K1.21M1.52M3.56M3.02M2.54M2.3M2.5M
Total Assets
65.24M▲ 0%
30.58M▼ 53.1%
28.72M▼ 6.1%
103.13M▲ 259.0%
127.27M▲ 23.4%
70.43M▼ 44.7%
38.99M▼ 44.6%
25.35M▼ 35.0%
11.22M▼ 55.8%
Asset Turnover0.75x1.64x1.69x0.08x0.58x0.79x0.77x1.34x2.60x
Asset Growth %-21.21%-53.12%-6.08%259.05%23.4%-44.66%-44.63%-34.98%-55.75%
Total Current Liabilities12.5M16.66M16.22M13.48M19.83M10.96M9.33M9.22M12.89M
Accounts Payable3.36M4.54M7.07M2.44M5.54M2.31M1.1M1.61M2.84M
Days Payables Outstanding31.1942.0468.1674.3248.8219.2315.1823.5645.87
Short-Term Debt08.49M03.3M3.58M0003.59M
Deferred Revenue (Current)04.22M279K914K549K339K861K1.14M1.13M
Other Current Liabilities8.06M2.5M2.45M287K4.37M3.14M2.37M3.52M2.41M
Current Ratio1.29x0.35x0.24x6.81x5.50x4.32x2.85x1.66x0.46x
Quick Ratio1.20x0.30x0.20x6.76x5.41x4.21x2.75x1.61x0.42x
Cash Conversion Cycle-14.46----30.229.0817.463.07-18.15
Total Non-Current Liabilities6.9M791K15.04M9.29M7.5M11.52M8.69M8.39M10.9M
Long-Term Debt6.5M05.76M2.35M00000
Capital Lease Obligations005.83M6.93M7.5M11.52M8.69M8.39M7.04M
Deferred Tax Liabilities000000000
Other Non-Current Liabilities404K791K3.45M000003.87M
Total Liabilities19.4M17.45M31.26M22.76M27.33M22.48M18.02M17.61M23.8M
Total Debt6.5M8.49M15.26M15.38M13.82M14.11M11.09M10.77M12.49M
Net Debt132K5.08M13.07M-74.42M-91.68M-4.93M2.66M6.22M9.87M
Debt / Equity0.14x0.65x-0.19x0.14x0.29x0.53x1.39x-
Debt / EBITDA----1.89x----
Net Debt / EBITDA-----12.55x----
Interest Coverage-20.89x-18.65x-6.13x-13.51x--53.14x-60.11x-67.60x-118.98x
Total Equity
45.84M▲ 0%
13.13M▼ 71.3%
-2.54M▼ 119.3%
80.37M▲ 3269.2%
99.94M▲ 24.3%
47.95M▼ 52.0%
20.97M▼ 56.3%
7.74M▼ 63.1%
-12.58M▼ 262.5%
Equity Growth %-28.57%-71.35%-119.31%3269.2%24.34%-52.02%-56.26%-63.08%-262.49%
Book Value per Share2468.18542.16-31.0336.0719.0210.245.021.68-2.26
Total Shareholders' Equity40.88M9.11M-6.24M77.81M92.73M39.93M13M-788K-22.04M
Common Stock265K352K52K941K1.01M832K42K53K61K
Retained Earnings-249.71M-286.91M-308.14M-398.62M-395.27M-428.11M-455.85M-472.71M-489.7M
Treasury Stock000000000
Accumulated OCI-74K-251K-283K-220K-312K-534K-1.92M-1.96M-1.54M
Minority Interest4.96M4.03M3.7M2.56M7.2M8.02M7.97M8.53M9.46M

XWEL Cash Flow Statement

XWELL, Inc. (XWEL) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Cash from Operations-12.17M-6.57M-113K-25.01M14.56M-24.19M-16.07M-11.01M-8.71M
Operating CF Margin %-24.93%-13.11%-0.23%-298.29%19.75%-43.24%-53.39%-32.47%-29.83%
Operating CF Growth %-44.2%46.06%98.28%-22034.51%158.22%-266.12%33.55%31.54%20.83%
Net Income-16.11M-35.63M-20.53M-92.23M2.89M-32.63M-27.74M-16.49M-16.11M
Depreciation & Amortization7.98M9.5M6.12M7.22M4.92M7.27M3.55M2.27M1.78M
Stock-Based Compensation2.18M916K335K1.33M2.86M3.87M2.32M893K1.08M
Deferred Taxes-3.47M19.23M4.61M000000
Other Non-Cash Items26K1.54M4.81M67.03M2.26M7.33M7.72M3.9M6.79M
Working Capital Changes-2.77M-2.12M4.54M-8.36M1.63M-9.94M-1.92M-1.58M-2.26M
Change in Receivables-636K-1.83M00-1.12M-1.83M1.19M-193K247K
Change in Inventory1.35M377K136K-10K-1.11M592K261K399K-8K
Change in Payables-3.11M-604K3.76M-5.17M6.69M-3.25M-488K387K1.21M
Cash from Investing-5.4M-1.87M-2.27M-4.35M-5.16M-34.84M5.65M5.89M4.33M
Capital Expenditures-4.71M-3.12M-2.27M-3.97M-4.28M-6.84M-1.91M-1.78M0
CapEx % of Revenue9.65%6.22%4.69%47.33%5.81%12.22%6.33%5.26%10.15%
Acquisitions276K800K178K02.43M-4.85M-1.39M00
Investments---------
Other Investing-960K335K-178K-380K-3.31M-34.84M-468K-9K-3.06M
Cash from Financing6.09M5.64M1.17M117.22M6.35M-27.38M8K1.36M1.94M
Debt Issued (Net)04.35M2.87M6.15M-2.07M-3.58M000
Equity Issued (Net)6.58M00110.62M9.26M-23.86M-22K1.35M157K
Dividends Paid00000000-267K
Share Repurchases0000-7.83M-23.86M-22K0-1.79M
Other Financing-497K1.29M-1.71M453K-841K69K30K4K2.05M
Net Change in Cash
-11.54M▲ 0%
-2.96M▲ 74.3%
-1.25M▲ 57.7%
87.87M▲ 7101.4%
15.76M▼ 82.1%
-86.47M▼ 648.8%
-10.6M▲ 87.7%
-3.89M▲ 63.3%
-2.43M▲ 37.4%
Free Cash Flow
-16.88M▲ 0%
-9.68M▲ 42.7%
-2.39M▲ 75.3%
-29.36M▼ 1129.5%
6.97M▲ 123.7%
-31.02M▼ 545.1%
-18.45M▲ 40.5%
-12.8M▲ 30.6%
-11.68M▲ 8.8%
FCF Margin %-34.58%-19.33%-4.92%-350.16%9.45%-55.46%-61.27%-37.75%-39.98%
FCF Growth %-85.91%42.66%75.34%-1129.52%123.74%-545.06%40.54%30.63%8.75%
FCF per Share-909.11-399.64-29.22-13.181.33-6.63-4.42-2.78-2.10
FCF Conversion (FCF/Net Income)0.42x0.18x0.01x0.28x4.35x0.74x0.58x0.65x0.51x
Interest Paid00735K187K11K10K000
Taxes Paid00124K11K055K35K59K58K

XWEL Key Ratios

XWELL, Inc. (XWEL) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2016201720182019202020212022202320242025
Return on Equity (ROE)-45.86%-52.43%-126.17%-400.47%-232.51%3.71%-44.41%-80.5%-117.39%-
Return on Invested Capital (ROIC)-47.02%-22.9%-81.15%-82.8%-364.87%43.37%-91.17%-63.48%-66.67%-124.76%
Gross Margin32.44%19.42%21.25%21.97%-42.91%43.87%21.54%12.23%26.31%22.75%
Net Margin-126.52%-59.07%-74.27%-43.75%-1079.17%4.54%-58.7%-92.14%-49.72%-58.17%
Debt / Equity0.10x0.14x0.65x-0.19x0.14x0.29x0.53x1.39x-
Interest Coverage-10.35x-20.89x-18.65x-6.13x-13.51x--53.14x-60.11x-67.60x-118.98x
FCF Conversion0.35x0.42x0.18x0.01x0.28x4.35x0.74x0.58x0.65x0.51x
Revenue Growth-16.37%157.32%2.6%-3.15%-82.72%779.3%-24.13%-46.18%12.58%-13.83%

XWEL SEC Filings & Documents

XWELL, Inc. (XWEL) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 1, 2026·SEC

Material company update

Mar 4, 2026·SEC

Material company update

Feb 25, 2026·SEC

10-K Annual Reports

3
FY 2026

Apr 1, 2026·SEC

FY 2025

Apr 15, 2025·SEC

FY 2024

Apr 16, 2024·SEC

10-Q Quarterly Reports

6
FY 2025

Nov 14, 2025·SEC

FY 2025

Aug 14, 2025·SEC

FY 2025

May 20, 2025·SEC

XWEL Frequently Asked Questions

XWELL, Inc. (XWEL) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

XWELL, Inc. (XWEL) reported $29.2M in revenue for fiscal year 2025.

XWELL, Inc. (XWEL) saw revenue decline by 13.8% over the past year.

XWELL, Inc. (XWEL) reported a net loss of $17.0M for fiscal year 2025.

Dividend & Returns

Yes, XWELL, Inc. (XWEL) pays a dividend with a yield of 3.78%. This makes it attractive for income-focused investors.

XWELL, Inc. (XWEL) had negative free cash flow of $11.7M in fiscal year 2025, likely due to heavy capital investments.

Explore More XWEL

XWELL, Inc. (XWEL) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.